Summary
The concentrations of somatomedins/insulin-like growth factors were measured by a specific radioimmunoassay for insulin-like growth factor-I and a specific radioreceptor assay for insulin-like growth factor-II in sera of term normal and Type 1 (insulin-dependent) diabetic pregnant women and in various cord sera of their newborn infants. Serum insulin-like growth factor-I levels in normal (non-diabetic) maternal serum were higher than in non-pregnant women (486 ± 26 versus 215 ± 26 ng/ml). The normal pregnancy-induced increment of insulin-like growth factor-I was markedly reduced in diabetic pregnancy. It was not different in patients with good or poor glycaemic control, as judged by normal or elevated blood levels of haemoglobin A1c content. Insulin-like growth factor-I levels in cord serum of infants of diabetic women with good glycaemic control (86±11 ng/ml) and poor glycaemic control (91±19 ng/ml) were significantly higher (p < 0.01) than in infants of non-diabetic women (43±42 ng/ml). The fetal birth weight ratios were not significantly correlated with insulin-like growth factor-I levels in cord serum. Serum insulin-like growth factor-II levels in maternal and cord serum in diabetic and normal pregnancy were not different from each other or from normal non-pregnant women. The increment in insulin-like growth factor-I levels in maternal serum in pregnancy may influence placental structure and function. Lack of this increment in maternal diabetes may have direct implication in placental abnormalities in diabetes and indirect implications on fetal development and metabolism. The increment in fetal serum insulin-like growth factor-I levels in infants of diabetic mothers might suggest a role for insulin-like growth factor-I in fetal macrosomia. This finding, along with the lack of correlation with maternal glycaemic control, might suggest that fetal hyperinsulinaemia has a greater role than insulin-like growth factor-I in the fetal macrosomia. Serum insulin-like growth factor-II levels do not appear to be influenced by pregnancy or diabetes. The similar levels of insulin-like growth factors-I or II in normal and diabetic non-pregnant women may present some evidence against a major role of both insulin-like growth factors in the chronic complications which may develop in persons with diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rinderknecht E, Humbel RE (1976) Polypeptides with non-suppressible insulin-like and cell-growth promoting activities in human serum: isolation chemical characterization and some biological properties of forms I and II. Proc Natl Acad Sci USA 73: 2365–2369
Bala RM, Bhaumick B (1979) Purification of a basic somatomedin from human plasma cohn fraction IV-I, with physicochemical and radioimmunoassay similarity to somatomedin-C and insulin-like growth factor. Can J Biochem Cell Biol 57: 1289–1298
Svoboda ME, Van Wyk JJ, Knapper DG, Fellow RE, Grissom FE, Schlneter RJ (1980) Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis and relationship to other somatomedins. Biochemistry 19: 790–797
Bhaumick B, Goren HJ, Bala RM (1981) Further characterization of human basic-somatomedin; comparison with insulin-like growth factors I and II. Horm Metab Res 13: 515–518
Klepper DG, Svoboda ME, Van Wyk JJ (1983) Sequence analysis of somatomedin-C; confirmation of identity with insulin-like growth factor-I. Endocrinology 112: 2215–2217
Moses AC, Nissley SP, Short PH, Rechler MM, Podskalny JM (1980) Purification and characterization of multiplication stimulating activity, insulin-like growth factors from rat liver conditioned medium. Eur J Biochem 103: 387–400
Wilson WM, Bennett A, Adamson GD, Nagashima RJ, Liu F, DeNatale ML, Hintz RL, Rosenfeld RG (1982) Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin content, peptide content in normal human pregnancy. J Clin Endocrinol Metab 55: 858–561
Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60: 648–657
Bala RM, Lopatke J, Leung A, McArthur RG (1981) Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth. J Clin Endocrinol Metab 52: 508–512
Whitsett JA, Brownscheidle CM (1979) Aspects of placental structure and function in maternal diabetes. In: Merkatz IR, Adama PAJ (eds) The diabetic pregnancy: a perinatal perspective. Grune and Stratton, New York, p 123
Susa JB, Widness JA, Hintz R, Lin F, Seghal P, Schwartz R (1984) Somatomedins and insulin in diabetic pregnancies: effects on fetal macrosomia in the human and rhesus monkey. J Clin Endocrinol Metab 58: 1099–1105
Rieu M, Binoux M (1985) Serum level of insulin-like growth factor (IGF) and IGF binding protein in insulin dependent diabetes during an episode of severe metabolic decompensation and the recovery phase. J Clin Endocrinol Metab 60: 781–785
Merimee TJ, Zapf J, Froesch ER (1983) Insulin-like growth factors, studies in diabetes with and without retinopathy. New Engl J Med 309: 527–530
Lamberton PR, Goodman AD, Kassoff A, Rubin CL, Treble DH, Saba TM, Merimee TJ, Dodds WJ (1984) Von Willebrand factor (VIII R: Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes 33: 125–129
Merimee TJ, Gardner DF, Zapf J, Froesch ER (1984) Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus. Diabetes 33: 790–793
Blethen SL, Sargeant DT, Whitlow MG, Santiago JV (1981) Effect of pubertal stage and recent blood glucose control on plasma somatomedin C in children with insulin-dependent diabetes mellitus. Diabetes 30: 868–872
Tamborlane WV, Raymond LH, Bergman M, Genel M, Felig P, Sherwin RS (1981) Insulin-infusion pump treatment of diabetes, influence of improved metabolic control on plasma somatomedin levels. New Engl J Med 305: 303–307
Horner JM, Kemp SF, Hintz RL (1981) Growth hormone and somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 53: 1148–1153
Brenner WE, Edelman DA, Hendricks CH (1976) Standards of fetal growth for the United States of America. Am J Obstet Gynecol 126: 555
Daughaday WH, Maritz IK, Trivedi B (1981) A preferential binding site for insulin-like growth factor II in human and rat placental membranes. J Clin Endocrinol Metab 53: 282–288
Bhaumick B, Bala RM (1985) Ontogeny and characterization of basic somatomedin receptors in rat placenta. Endocrinology 116: 492–497
Zapf J, Schoenle U, Froesch ER (1978) Insulin-like growth factors I and II: some biological actions receptor binding characteristics of two purified constituents of non-suppressible insulin-like activity from human serum. Eur J Biochem 87: 285–296
Bala RM, Bhaumick B (1979) Radioimmunoassay of a basic somatomedin: comparison of various assay techniques and somatomedin levels in various sera. J Clin Endocrinol Metab 49: 770–777
Daughaday WH, Parker KA, Borowsky S, Trivedi B, Kapadia M (1982) Measurement of somatomedin-related peptides in fetal, neonatal and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay. IGF-II radioreceptor assay (RRA) and multiplication stimulating RRA after acid-ethanol extraction. Endocrinology 110: 575–581
Zapf J, Walter H, Froesch ER (1981) Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 68: 1321–1330
Schimpff RM, Bozzola M, Zapf J (1985) Serum thymidine activity and insulin-like growth factors in the neonatal period. Acta Endocrinol 110: 140–144
Bennet A, Wilson DFM, Liu F, Nagashima R, Rosenfeld RG, Hintz RL (1983) Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocrinol Metab 57: 609–611
Gluckman PD, Johnson-Barret JJ, Butler JH, Edgar BW, Gun TR (1983) Studies on insulin-like growth factor I and II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxf) 19: 405–413
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bhaumick, B., Danilkewich, A.D. & Bala, R.M. Insulin-like growth factors (IGF) I and II in diabetic pregnancy: Suppression of normal pregnancy-induced rise of IGF-I. Diabetologia 29, 792–797 (1986). https://doi.org/10.1007/BF00873218
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00873218